Kevin Pong, MBA, PhD

Kevin Pong serves as Anima Biotech's Chief Business Officer and joined in 2018 as Vice President of Business Development. He brings more than 20 years of scientific, strategic, business development, and alliance management experience from large, medium, and small biotech and pharmaceutical companies. He joins Anima from Summit Therapeutics where he served as vice president of business development, licensing, and alliance management. Prior to Summit, he led the identification, evaluation, and negotiation of CNS business development opportunities at Sunovion Pharmaceuticals. Prior to Sunovion, he supported and led business and corporate development efforts for the branded pharma and device business units at Endo Pharmaceuticals. Prior to joining Endo, he held leadership roles in discovery neuroscience research at Wyeth. Dr. Pong holds a B.S. in Biological Sciences and a Ph.D. in Neuroscience from the University of Southern California and an MBA from Rutgers University.